Skip to content
Screener

Net Income at other companies

Castle Biosciences logo
Castle BiosciencesCSTL
-$14.52M+43.8%
Guardant Health logo
Guardant HealthGH
-$112.08M-17.8%
Insight Molecular Diagnostics Inc. logo
Insight Molecular Diagnostics Inc.IMDX
-$11.26M-15.6%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
-$7.27M+36.6%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
-$24.83M-115%
Personalis, Inc. logo
Personalis, Inc.PSNL
-$30.03M-90.7%

Other financials

Income statement

See full
Revenue$1.5M+26.7%
Gross profit$29.0K+107%
Operating income-$12.8M-12.4%
EPS (diluted)-$0.10+60.0%

Balance sheet

See full
Cash & equivalents$33.4M+7.4%
Total debt$1.4M-37.5%
Total equity$10.9M+39.0%
Total assets$38.9M+0.7%

Cash flow

See full
Operating cash flow-$11.3M-7.1%
CapEx$21.0K-16.0%
Free cash flow-$11.3M-7.0%

Valuation

See full
Market cap$185.35M+44.4%
Enterprise value$153.36M+54.1%
P/S34×+4.6×

Profitability

See full
Gross margin-57.3%
Operating margin-930.9%-124pp
Net margin-959.8%-187pp
FCF margin-1,040.1%

Returns & leverage

See full
Return on equity-556.3%+139pp
Debt / equity0.1×-0.2×
Current ratio1.3×+0.2×

Where this comes from

Reported directly by Lucid Diagnostics in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The source filing: Lucid Diagnostics’s 10-Q, filed August 12, 2026. Open the filing →

Filed
Aug 12, 2026, 4:30 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001437749-26-027335

FAQ

What is Lucid Diagnostics's net income?
Lucid Diagnostics (LUCD) reported net income of -$11.69M in Q2 2026.
How has Lucid Diagnostics's net income changed year-over-year?
Lucid Diagnostics's net income decreased by 163.3% year-over-year, from -$4.44M to -$11.69M.
What is the long-term trend for Lucid Diagnostics's net income?
Over 4 years (2021 to 2025), Lucid Diagnostics's net income has grown at a 19.9% compound annual growth rate (CAGR), from -$28.08M to -$58.01M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

Ask your AI about Lucid Diagnostics's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude